Psoriasis is usually more extensive and severe in skin of color. Hear dermatologist Dr. Mona Shahriari from Central Connecticut Dermatology address why and how psoriasis presents in skin of color, potential for misdiagnosis, hyper/hypopigmentation, cultural beliefs, and cautions to consider when treating psoriasis in skin of color. This program is supported by educational grants from Amgen, Bristol Myers Squibb, CeraVe, Janssen, and UCB.

Do you want to make your dermatology health care appointments more effective? Not sure if you're preparing enough for your appointments? Hear Kirk Gautier, a certified physician assistant with US Dermatology Partners in Tyler and Athens, TX offer tips from what to bring and do to help prepare and make the most of your health care appointments. This Psound Bytes episode is provided with support from Bristol Myers Squibb, Janssen and UCB,

Transitions in life impact us all. When it impacts your psoriatic disease care you need options. Listen as we discuss transitions that might mean a change in your treatment such as pregnancy, surgery, insufficient efficacy, and more with NPF Medical Board member Dr. Clive Liu, Director of the Psoriasis Treatment Center at Bellevue Dermatology. This Psound Bytes episode is provided with support from Bristol Myers Squibb, Janssen, and UCB.

Adhering to treatment can be challenging. So many factors impact adherence and ultimately treatment outcomes. Listen as we explore the issues of why treatment adherence matters and what you can do about it with the leading expert on this topic, dermatologist and skin pathologist Dr. Steven Feldman from Wake Forest School of Medicine in Winston-Salem, NC.

You may have heard about erythrodermic psoriasis but just what is it? Dr. Mio Nakamura from the University of Michigan, Dept. of Dermatology answers questions about this serious and potentially life-threatening form of psoriasis from types, symptoms, need for acute care, to potential triggers, treatment options and risk of skin infections. This Psound Bytes episode is provided with support from AbbVie, Amgen, Bristol Myers Squibb and Janssen.

Have questions about JAK inhibitors? Not sure how they work, what they treat, risks and how effective they are compared to other treatments? Listen as rheumatologist and NPF Medical Board member, Dr. Sergio Schwartzman from Weill Cornell Medical Center in NY, addresses such questions and more about the JAK STAT pathway. This Psound Bytes episode is provided with support from AbbVie, Amgen, Bristol Myers Squibb and Janssen.

Topical therapies are a mainstay of psoriasis care but can be challenging to use. Hear what challenges they present and how the latest topicals - Tapinarof and Roflumilast could revolutionize topical treatments from dermatologist and NPF Medical Board member, Dr. Larry Green, Aesthetics and Dermatology Center in Rockville, MD. This Psound Bytes episode is provided with support from AbbVie, Amgen, Bristol Myers Squibb and Janssen.

Join dermatologist Dr. Jason Hawkes, Associate Professor of Dermatology at the University of California, Davis, as he breaks down the immune pathways and feed forward mechanism driving the development of psoriasis and psoriatic arthritis, and why the IL-17/IL-23 axis is key to the development of targeted treatments for this disease. This Psound Bytes episode is provided with support from AbbVie, Amgen, Bristol Myers Squibb and Janssen.

Treatment options backed by real-world evidence means more opportunities for those living with moderate-to-severe plaque psoriasis. Join Steve Rozzo, Ph.D., Sun Pharma, and Neal Bhatia, M.D., Therapeutics Clinical Research in San Diego, CA in a Q&A discussion on real-world clinical data of ILUMYA® and what the findings mean for moderate-to-severe plaque psoriasis patients. Episode sponsored by Sun Pharma. Important safety information: https://bit.ly/2We7fIS .

Hear renowned rheumatologist Dr. Elaine Husni from the Arthritis and Musculoskeletal Treatment Center at Cleveland Clinic discuss with patients Brian LaFoy and Brandon Robert myths and solutions for changing lifestyle habits that can impact PsA and SpA care. This is the last episode in CAPES (Clinician and Patient Education Series) presented by NPF, GRAPPA, SPARTAN and SAA. This program is supported by an educational grant from Pfizer Inc.